Platform Licensing: Biotech and Pharma Perspectives
June 16, 2025
Breakout Session

This past year has seen many early-stage deals involving platform technologies ranging from AI drug discovery to building blocks for gene therapy products. In this panel, speakers will explore platform technologies from a variety of different perspectives, including addressing the benefits of having a platform, what makes something a platform, different types of platforms, how platforms impact deal structures, and the complexities platforms introduce in negotiations. Additionally, panelists will discuss real-world examples to illustrate the practical applications and challenges of implementing these technologies across various sectors. Attendees will experience an insightful and engaging discussion on the future of platform technologies.
Moderator
Speakers

Senior Vice President, Deputy General Counsel, Transactions
Bristol Myers Squibb